Vanguard Capital Management’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.8M Buy
937,950
+149,310
+19% +$6.3M ﹤0.01% 1924
2026
Q2
$21.9M Sell
788,640
-27,212
-3% -$642K ﹤0.01% 2402
2026
Q1
$17.6M Buy
+815,852
New +$15.1M ﹤0.01% 2417

Other funds holding PLSE

Vanguard Capital Management's PLSE Position: Q3 2026 in Review

Vanguard Capital Management increased its Pulse Biosciences (PLSE) stake by 19% in Q3 2026, buying an estimated $6.3M and bringing the position to 937,950 shares worth $46.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

Vanguard Capital Management first reported a position in PLSE in Q1 2026 and has held it in 3 quarters since. 141 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Vanguard Capital Management held 937,950 shares of Pulse Biosciences worth $46.8M as of Q3 2026.
  • Vanguard Capital Management bought 149,310 Pulse Biosciences shares in Q3 2026, an estimated $6.3M.
  • Pulse Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1924 holding.
  • Vanguard Capital Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 141 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.